AIM ImmunoTech Inc. (AIM): Forvard P/S multiplikatori
AIM ImmunoTech Ampligen dori vositasining noyobligiga asoslangan barqaror daromad keltiradi. GURU.Markets kunlik grafigidagi kutilayotgan narx-sotuvlar nisbati ushbu tendentsiyani tasdiqlaydi, bunda ko'rsatkich darajasi 60.40 ni tashkil etadi. Terapiyaning iqtisodiy sikllardan mustaqilligi biznes barqarorligini kafolatlaydi, laboratoriyalarning modernizatsiyasi esa hozirda kompaniyani yangi klinik seriyalar ishlab chiqarish hajmini oshirishga tayyorlamoqda.
AIM ImmunoTech kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati AIM ImmunoTech|AIM - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech Inc.|AIM - Kompaniyaning umumiy qarzi|Qarzning balans kapitallashuviga nisbati AIM ImmunoTech Inc.|AIM - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli majburiyatlari AIM ImmunoTech|Tezkor likvidlik aimimmuno.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
AIM - Kompaniya foydasi|Kutilayotgan foyda AIM ImmunoTech|AIM - Kapitalizatsiyaning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati AIM ImmunoTech|AIM - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori AIM ImmunoTech Inc.|AIM - Foizlar, soliqlar va eskirishdan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) AIM ImmunoTech|AIM - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi aimimmuno.com|AIM - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi AIM ImmunoTech
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning barcha koʻrsatkichlari tahlili:AIM (AIM ImmunoTech)
AIM ImmunoTech (AIM) kompaniyasining fundamental qiymatini baholash uchun investorlar joriy bozor kapitalizatsiyasini prognoz qilingan savdo hajmlari bilan solishtirishlari kerak. Forward P/S koeffitsiyentini tahlil qilish foyda hisobotlari e'lon qilinishidan oldin bozor kutganlarini kuzatish imkonini beradi, bunda ushbu ko'rsatkichning o'sishi, keng doiradagi chakana savdo treyderlari orasida kompaniyaga nisbatan noaniq qarashlar mavjudligiga qaramay, Ampligen ning terapevtik salohiyatiga bo'lgan ishonchni aks ettiradi.
AIM ImmunoTech (AIM) raqobatchilari
Forvard P/S multiplikatori ARGX (argenx)|Forvard P/S multiplikatori BioNTech Inc. BNTX|Abivax Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ADMA Corp ADMA|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori immunovant.com|Forvard narx/daromad multiplikatori KNSA|GRFS: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ADPT|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Celldex Corp|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|BCRX - Forvard narx/daromad multiplikatori|VERA - Narxning prognoz qilingan daromadga nisbati|Dianthus Therapeutics Inc (DNTH) - Forvard narx/daromad multiplikatori|PHVS (Pharvaris Corp) - Forvard narx/daromad multiplikatori|AbCellera Corp (ABCL) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Tourmaline Bio, Inc.|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PGEN (precigen.com)|Narxning prognoz qilingan daromadga nisbati Pharming Group (PHAR)|NKTR - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Upstream Bio Corp - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ZBIO (Zenas Corp)|Immunome, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati gossamerbio.com|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|SVRA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori RIGL|Forvard P/S multiplikatori anaptysbio.com (ANAB)|Forvard P/S multiplikatori ATXS (Astria Therapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc (ENGN)|RAPT - Narxning prognoz qilingan daromadga nisbati|Aerovate Therapeutics Inc (JBIO) - Forvard narx/daromad multiplikatori|Aclaris Therapeutics (ACRS) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati KYTX (kyvernatx.com)|TLSA (Tiziana Life Sciences Ltd) - Forvard P/S multiplikatori|CABA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori VTYX|Forvard P/S multiplikatori Theratechnologies, Inc (THTX)|Narxning prognoz qilingan daromadga nisbati Avalo Therapeutics, Inc AVTX|Sotuvga nisbatan forvard narx ELDN|AGEN - Narxning prognoz qilingan daromadga nisbati|Climb Bio Inc. (CLYM) - Forvard narx/daromad multiplikatori|ZURA: Forvard P/S multiplikatori|aTyr Pharmaceuticals (ATYR) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori ADAG|IMA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori STTK|Kapitalizatsiyaning kutilayotgan sotuvga nisbati equilliumbio.com|Narxning prognoz qilingan daromadga nisbati Connect Biopharma Holdings Limited CNTB|IMUX - Forvard narx/daromad multiplikatori|ATRA - Narxning prognoz qilingan daromadga nisbati|InflaRx N.V. (IFRX) - Forvard narx/daromad multiplikatori|XFOR (X4 Pharmaceuticals, Inc.) - Forvard narx/daromad multiplikatori|Adicet Bio, Inc. (ACET) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Celularity Inc|Kapitalizatsiyaning prognoz qilingan daromadga nisbati INMB (INmune Bio Corporation)|Forvard P/S multiplikatori BRNS|KZR - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori SABS (SAB Biotherapeutics, Inc.)|Forvard P/S multiplikatori Akari Therapeutics PLC AKTX|Enlivex Therapeutics, Ltd. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Q32 Bio Inc. QTTB|GeoVax Labs, Inc. (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori edesabiotech.com|Forvard narx/daromad multiplikatori IBIO|CARM: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori XTLB|Kapitalizatsiyaning kutilayotgan sotuvga nisbati boltbio.com|Narxning prognoz qilingan daromadga nisbati HCW Biologics HCWB|APVO - Forvard narx/daromad multiplikatori|ADTX - Narxning prognoz qilingan daromadga nisbati|GRI Bio Inc (GRI) - Forvard narx/daromad multiplikatori|XRTX (XORTX) - Forvard narx/daromad multiplikatori|Vyome Therapeutics (HIND) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Revelation Biosciences|Kapitalizatsiyaning prognoz qilingan daromadga nisbati INDP (indaptusrx.com)|Narxning prognoz qilingan daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|CALI - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Affimed N.V. - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ALLK (Allakos Inc)|HOOKIPA - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati IGM Biosciences, Inc.|ITOS: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Ocean Biomedical Inc|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|THRD: Sotuvga nisbatan forvard narx
